APOE genotyping is sometimes used as an adjunct test to help in the diagnosis of probable late onset Alzheimer disease (AD) in symptomatic adults. It is called susceptibility or risk factor testing because it may indicate whether there is an increased risk of AD but is not specifically diagnostic of AD.